Intellipharmaceutics International Inc. (IPCI)

[numbersarefun]

FocalinXR is DEA_Schedule_II controlled drug, SeroquelXR is not. Generic SeroquelXR will be under way more pricing pressure because of way more ANDA competitors and no quantity limits. Generic companies will try to flood market with generic SeroquelXR with as much as they can afford to produce. There will probably be competition from foreign manufacturers.

Since FocalinXR is DEA Schedule II controlled, there is a quota limit which probably prevents flooding the market. Schedule II drugs can only be produced in the United States, which limits competition from foreign manufacturers.